BD Evolve™ On-body Injector - Enabling new drug delivery regimens

Product description

BD Evolve™ On-body Injector* is being developed for pharmaceutical companies who seek flexible delivery options, as well as opportunities for improving the patient experience and lowering the cost of care. It supports delivery of biologics with customizable and programmable subcutaneous administration. BD Evolve™ On-body Injector is designed as a flexible system capable of continuous, episodic, or delayed delivery across a range of volumes, for extended wear and injection durations. It is meant to be programmable, with connected capabilities, and to enable subcutaneous administration of up to 3 mL of medication with up to 3 days of wear, allowing for medication delivery in a non-clinical setting.      

BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.                                                                                                     

* BD Evolve™ is a product in development; some statements are subject to a variety of risks and uncertainties.
BD, the BD Logo and BD Evolve are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved.
Read more


Categories Pharmaceutical PackagingDrug Delivery Systems; Pharmaceutical PackagingPrimary Packaging; Pharmaceutical PackagingSyringes/prefilled syringes
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

More products from BD

View all our products (27)

Products from other suppliers